Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904871-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 13.4;granulocytes: 43.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065887	Supported	Supported			"Secreted in other tissues"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	1.8	0.2	1.9	10.9	2.6	0.0	1.3	0.3	2.9	2.1	0.0	1.8	0.1	3.0	0.0	1.3	0.4	7.1	0.5	2.7	21.7	0.5	0.2	1.6	1.0	31.9	6.8	0.1	4.8	0.2	3.5	0.1	13.7	1.4	1.1	0.3	1.9	0.5	0.2	0.7	1.3	1.0	5.4	0.1	1.5	2.5	17.7	0.4	0.2	0.0	1.0	2.3	1.3	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.3	2.9	2.7	21.7	31.9	6.8	13.7	5.4	17.7	2.0	0.2	3.2	0.6	0.3	0.0	0.6	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	13.4	0.0	0.0	2.4	0.0	0.0	43.1	0.0	0.4	0.0	0.1	0.0	0.5	0.0	4.1	0.0	0.9	1.5	0.3	0.2	0.0	1.9	0.0	0.2	0.0	0.5	1.1	2.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.6	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.2
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.8;liver: 17.4;lymphoid tissue: 11.7;pancreas: 9.5;testis: 25.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1;Proximal tubular cells: 38.1;Spermatogonia: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.8;EFO-21: 20.1;PC-3: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	2.3	0.8	0.7	0.4	0.6	2.4	1.5	0.9	1.0	2.3	0.6	1.7	1.6	1.3	0.8	1.5	2.2	1.9	2.5	0.6	0.5	16.8	17.4	3.5	0.9	1.0	0.6	0.6	9.5	0.6	0.5	3.1	0.8	1.0	2.3	0.1	3.8	0.8	0.5	1.8	1.0	2.3	0.6	11.7	4.0	25.8	0.7	4.1	2.2	1.4	1.2	1.4	0.8	0.7	1.5	25.8	0.2	2.4	0.0	1.1	0.7	0.6	2.7	2.9	1.1	5.8	0.1	0.3	20.1	0.9	14.1	7.5	0.0	1.2	1.9	5.4	0.6	6.2	12.6	12.5	0.0	0.0	0.0	6.6	0.2	0.2	0.1	0.3	9.4	1.9	0.1	5.9	1.7	1.8	5.4	0.1	12.2	3.6	53.5	0.1	11.1	5.8	8.0	4.2	2.6	2.6	0.7	1.4	9.0	1.3	0.1	0.7	8.1	0.1	1.8	1.3	3.9	0.4	5.1	0.2	0.8	0.0	14.2	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.1	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.7	0.6	0.9	1.0	0.6	0.5	1.0	0.6	0.8	0.6	0.7	0.7	10.7	0.0	0.0	0.0	1.1	1.9	1.1	0.7	2.2	0.0	0.8	0.9	0.5	12.8	1.0	0.0	0.0	0.1	0.1	0.9	41.1	1.1	2.4	1.2	0.3	11.1	10.7	7.2	0.1	2.0	0.1	1.2	2.6	0.3	1.3	3.4	20.0	12.6	4.7	0.0	0.3	0.3	2.0	4.6	4.4	8.0	1.8	3.3	16.0	1.0	0.3	0.0	0.0	0.0	0.1	0.9	0.5	0.7	0.0	0.6	0.0	38.1	4.8	0.0	0.0	0.0	0.6	1.6	126.5	2.4	3.1	0.1	0.3	5.7	1.6	0.6
BAIAP3	"BAP3, KIAA0734"	ENSG00000007516	"BAI1 associated protein 3"	O94812	16	1333638-1349441	"Predicted intracellular proteins"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 221.6;pituitary gland: 367.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.5;Endometrial ciliated cells: 23.5;Enteroendocrine cells: 50.3;Excitatory neurons: 19.2;Respiratory ciliated cells: 45.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.2;MCF7: 6.2;RT4: 5.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 123.4"	"Low region specificity"	"Detected in all"			"HPA015627, HPA015979"	Uncertain	Supported				NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA015627: AB_10603678, HPA015979: "	"unprognostic (1.37e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.52e-5)"	"unprognostic (5.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.43e-2)"	3.2	19.3	87.5	1.1	86.9	0.9	5.1	2.3	74.9	5.0	11.5	4.0	3.9	1.2	1.9	2.2	31.2	0.5	4.0	60.7	221.6	12.5	8.1	6.1	1.3	59.8	108.9	0.8	8.0	3.6	367.9	1.8	58.8	9.7	0.8	0.7	4.8	2.4	2.7	2.1	13.5	0.1	37.5	6.8	6.0	20.5	181.6	0.3	1.6	1.1	0.7	2.6	2.0	26.4	0.1	2.3	4.0	1.3	0.4	0.0	1.0	0.2	0.1	0.2	0.0	3.6	20.2	0.3	2.7	0.0	0.1	0.1	0.0	0.2	0.0	0.2	1.3	0.1	0.4	1.4	0.3	0.0	2.7	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.7	0.0	0.0	6.2	0.0	0.8	2.3	1.0	3.4	0.6	0.0	4.0	2.3	5.6	0.5	0.2	0.0	1.8	0.1	1.1	4.3	0.3	0.3	0.0	2.2	0.5	0.0	1.5	0.5	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.3	0.0	0.1	1.6	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	87.5	86.9	2.3	74.9	60.7	221.6	59.8	108.9	58.8	37.5	181.6	26.4	5.6	0.0	0.0	21.5	7.7	0.5	3.3	2.4	1.8	1.6	2.5	1.9	1.3	0.0	4.9	5.5	0.0	0.2	1.9	2.8	0.0	0.7	4.0	23.5	0.9	2.3	50.3	2.7	19.2	0.2	0.3	0.6	4.1	3.7	0.0	2.0	2.9	4.7	0.1	0.0	13.2	3.2	8.2	0.0	0.4	2.0	0.6	0.2	1.8	1.0	0.1	0.8	0.0	1.5	2.3	0.2	0.8	0.0	4.0	2.9	4.0	0.6	45.7	0.6	6.6	0.9	2.7	2.6	1.8	1.6	0.4	1.1	1.7	0.1	2.9	1.9
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	9	"Enteroendocrine cells: 20.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Cell line enriched"	"Detected in single"	4	"THP-1: 2.6"	"Not detected"	"Not detected"							HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.2	0.6	0.3	0.1	0.3	0.1	0.1	1.2	0.7	0.1	0.2	0.3	0.7	0.0	0.1	0.6	0.0	0.3	0.6	0.2	0.3	0.0	0.2	0.4	0.6	0.2	0.5	0.0	4.4	0.1	0.2	0.2	0.3	0.1	0.6	0.0	0.2	0.0	16.5	0.0	0.3	0.0	0.2	0.6	1.9	0.5	0.7	0.1	0.2	3.7	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.2	0.7	0.2	0.3	0.2	0.5	0.3	0.2	0.7	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.8	0.0	0.8	0.6	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C22orf42		ENSG00000205856	"Chromosome 22 open reading frame 42"	Q6IC83	22	32149006-32159322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	13	"brain: 12.5;testis: 10.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 95.7;Late spermatids: 31.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.8;prostate cancer: 1.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 8.9;midbrain: 4.5;pons: 4.5;thalamus: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019531	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA019531: AB_1853016"					"unprognostic (5.67e-2)"						"unprognostic (6.13e-3)"	"unprognostic (8.21e-3)"		"unprognostic (7.06e-2)"	"unprognostic (4.54e-2)"			0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.8	4.5	0.0	0.4	0.0	0.9	0.0	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	10.6	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.1	0.4	0.0	8.9	0.8	4.5	4.5	0.4	12.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.7	0.2	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
EIF4E1B	FLJ36951	ENSG00000175766	"Eukaryotic translation initiation factor 4E family member 1B"	A6NMX2	5	176630618-176646644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.1;epididymis: 1.1;retina: 2.7"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 8.5;Cardiomyocytes: 12.8;Cone photoreceptor cells: 16.7;Excitatory neurons: 7.1;Horizontal cells: 11.8;Inhibitory neurons: 8.4;Rod photoreceptor cells: 17.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"T-47d: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045045	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA045045: AB_2679197"	"unprognostic (6.54e-2)"				"unprognostic (1.53e-2)"					"unprognostic (7.44e-2)"	"unprognostic (5.26e-2)"				"unprognostic (1.86e-1)"			0.0	0.2	1.1	0.0	1.4	0.2	0.0	1.5	3.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.5	3.1	1.3	0.8	1.1	0.9	1.1	0.6	0.7	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	12.8	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	8.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 2.8;brain: 4.8;ovary: 2.5;pancreas: 4.4"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;granulocytes: 1.3;Granulosa cells: 1.4"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.6"	"Not detected"	"Not detected"							HPA048933			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA048933: "	"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.5	0.1	2.1	2.8	0.0	1.4	1.9	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	1.5	0.0	0.0	0.1	0.4	2.1	1.6	2.5	4.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.3	0.6	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	2.1	1.4	1.9	1.3	1.5	2.1	1.6	2.1	1.3	1.9	4.8	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.3	1.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901291-168910000	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"pancreas: 30.9;retina: 12.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 17.8;Muller glia cells: 53.0"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	53.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216665-26304558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 37.6;retina: 9.5"	"Cell type enriched"	"Detected in some"	13	"Inhibitory neurons: 293.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			0.0	0.0	13.1	0.0	37.3	0.0	0.0	6.9	16.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	37.6	0.0	0.0	0.0	0.0	6.6	14.8	0.0	3.6	0.0	0.4	0.0	7.7	0.0	0.0	9.5	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.1	0.4	11.9	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	37.3	6.9	16.2	6.0	37.6	6.6	14.8	7.7	3.1	11.9	3.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	293.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.6	0.0	0.3	0.0	2.0	6.1	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754998	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.9;pituitary gland: 7.5;retina: 21.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.2;Cone photoreceptor cells: 39.6;Horizontal cells: 6.7;Rod photoreceptor cells: 13.7"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"								"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.0	5.9	1.1	0.0	0.6	0.0	0.0	1.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.7	1.1	0.3	0.0	0.0	0.0	3.2	1.4	0.0	3.9	0.0	7.5	0.0	1.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.6	1.1	1.4	0.7	1.1	3.2	1.4	1.0	0.2	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.8	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924851	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.4;Excitatory neurons: 1.7;Horizontal cells: 1.7;Inhibitory neurons: 5.0;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"hypothalamus: 9.4;midbrain: 15.1;pons and medulla: 26.3"	"Low region specificity"	"Detected in many"			CAB079042		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 56: Bipolar cells - Visual perception"			"CAB079042: "					"unprognostic (3.17e-1)"						"unprognostic (2.47e-1)"		"unprognostic (3.85e-7)"	"unprognostic (8.24e-2)"		"unprognostic (9.45e-3)"		0.0	0.3	1.9	0.0	0.6	0.0	0.0	12.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.0	40.7	13.9	0.0	0.2	0.0	0.0	0.0	31.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	12.2	1.8	0.2	7.0	40.7	13.9	31.4	20.9	12.1	10.9	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.0	0.1	0.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.5
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19254756-19262804	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 107.1"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 16.0;Hepatocytes: 6.7;Inhibitory neurons: 19.9;Proximal enterocytes: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;NTERA-2: 8.3;SCLC-21H: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.1	1.0	5.8	0.1	3.7	0.2	0.2	18.3	107.1	2.0	0.0	0.2	12.4	0.8	0.1	0.0	0.2	0.2	0.1	10.7	20.0	0.5	14.1	0.1	0.1	46.6	9.7	0.6	0.9	0.0	0.7	0.2	43.2	0.6	0.1	2.3	0.1	0.3	0.0	0.2	15.4	0.2	10.9	0.1	0.3	0.1	33.6	0.0	0.0	0.0	0.0	0.1	0.5	35.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	3.5	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.0	0.4	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.7	18.3	107.1	10.7	20.0	46.6	9.7	43.2	10.9	33.6	35.6	0.1	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	16.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.4	6.7	0.1	0.0	19.9	0.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	15.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 241.1;heart muscle: 521.2;skeletal muscle: 282.3;tongue: 154.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.2;thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018174	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	0.5	0.7	77.5	0.0	163.6	0.0	1.3	124.7	110.1	0.5	34.3	0.3	0.0	0.9	0.4	4.0	1.8	0.4	521.2	76.0	109.5	0.3	0.3	0.7	0.3	152.8	152.1	0.1	1.3	2.9	3.8	0.1	149.3	1.7	0.1	37.8	10.7	0.2	282.3	1.3	0.2	0.2	101.0	0.2	0.2	1.1	127.8	2.2	21.4	154.2	0.1	0.1	0.3	241.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.5	163.6	124.7	110.1	76.0	109.5	152.8	152.1	149.3	101.0	127.8	241.1	0.0	0.0	0.0	59.1	0.0	0.4	0.0	0.0	0.0	119.6	0.0	0.0	65.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.1	1.2	0.0	0.0	4.8	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	11.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	5.4	2.8	0.0	49.9	0.0	1.5	168.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.2	0.0	5.5	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
IAPP	"AMYLIN, DAP, IAP"	ENSG00000121351	"Islet amyloid polypeptide"	P10997	12	21354959-21379980	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"pancreas: 166.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 44.5;Pancreatic endocrine cells: 15.2"	"Cancer enriched"	"Detected in single"	76	"pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000352, HPA053194"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	11900		"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"CAB000352: AB_2121635, HPA053194: AB_2682076"							"unprognostic (5.52e-3)"				"unprognostic (1.00e-1)"	"unprognostic (4.16e-1)"		"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"			0.5	0.0	0.1	0.0	0.2	1.0	0.0	0.5	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	2.3	0.0	0.2	0.1	0.5	0.0	166.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.3	0.1	0.2	0.1	0.5	0.2	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	44.5	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.5	0.3	0.3	0.2	0.0	0.4	0.3	0.3	0.1	0.0	0.8
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 12983.6"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000			"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.2	4.0	0.1	0.2	0.1	49.8	0.6	0.0	0.0	0.7	0.0	12.8	1.5	1.4	0.0	1.8	0.3	3.7	5.6	0.1	0.1	40.7	1.4	1.7	5.4	0.2	0.4	2.6	12983.6	0.0	0.3	1.4	0.8	0.5	0.0	0.0	3.1	0.0	0.3	96.4	0.7	0.0	0.0	1.4	42.2	0.3	0.0	0.0	1.3	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"pancreas: 9.1"	"Cell type enriched"	"Detected in single"	11	"Hepatocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 2: Hepatocytes - Metabolism"			"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium inwardly rectifying channel subfamily J member 6"	P48051	21	37607373-38121345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 24.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 152.6;Horizontal cells: 245.6;Inhibitory neurons: 146.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	6	"cerebral cortex: 10.3;hippocampal formation: 10.6;midbrain: 24.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.2;eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	0.0	0.1	2.3	0.1	2.7	0.1	0.0	1.6	10.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.6	1.9	0.0	0.0	0.1	0.2	1.9	24.2	0.0	0.4	0.0	1.7	0.4	2.2	0.2	0.0	1.0	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.6	0.0	0.0	0.0	3.5	0.1	29.2	0.1	0.0	0.0	0.3	0.0	2.8	0.0	0.1	1.0	4.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.3	0.1	0.1	0.2	4.3	1.2	0.0	0.0	0.0	0.0	2.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	2.3	2.7	1.6	10.3	10.6	1.9	1.9	24.2	2.2	1.2	1.8	1.5	0.2	0.0	1.1	2.3	0.0	0.1	0.4	0.1	0.0	25.4	0.2	0.3	34.3	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.1	0.2	1.6	41.4	0.0	152.6	0.0	0.4	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	245.6	146.2	1.8	2.0	0.0	0.0	0.0	0.6	0.0	3.6	16.9	0.0	1.2	0.0	38.2	1.5	0.6	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.6	0.0	0.2	1.1	0.0	1.7	0.0	0.1	0.3	0.1	0.0	0.4	0.4
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pancreas: 23.7;stomach 1: 10.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	390	"SCLC-21H: 127.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"														"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	10.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391591-40587364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.4;retina: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4;cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 1.7;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.0	0.3	1.6	0.0	6.4	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.7	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	6.4	0.0	5.9	1.3	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.3	0.6	0.0	0.1	0.0	62.6	0.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	4.2	0.0	111.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	62.8	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	3.7	0.0	0.8	0.0	49.8	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.3	0.2	0.0	0.1	0.1
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926036-67101551	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4"	"Group enriched"	"Detected in some"	22	"Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HAP1: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies"	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.1	2.6	2.7	0.0	3.1	0.0	0.0	1.0	4.8	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.9	0.7	0.0	0.0	0.2	0.0	0.0	0.6	2.7	1.0	0.0	3.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.1	1.0	4.8	3.9	0.7	0.0	0.6	0.0	0.1	1.0	3.4	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.0	0.0	0.2	0.2	0.0	0.0	485.6	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	577.7	0.0	0.0	0.0	0.0	178.7	8.7	0.1	0.0	8.4	0.0	0.4	0.0	601.7	253.5	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.3	2.5	1.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0
MAFA	"hMafA, RIPE3b1"	ENSG00000182759	"MAF bZIP transcription factor A"	Q8NHW3	8	143419182-143430732	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 25.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 42.7;Skeletal myocytes: 12.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"spinal cord: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;MCF7: 1.9;RH-30: 1.2;SCLC-21H: 2.8;T-47d: 2.6;U-2 OS: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (5.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.42e-8)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-2)"	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.0	0.9	0.5	0.0	2.4	0.5	0.5	0.3	0.4	0.1	0.0	0.1	0.4	0.0	25.6	0.2	0.0	0.0	2.8	0.1	0.1	3.9	0.5	0.0	0.2	1.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.3	0.3	0.0	0.1	0.3	1.2	0.2	0.0	0.0	2.8	0.1	0.7	0.0	0.0	0.4	2.6	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	0.4	0.2	0.9	0.5	0.4	2.8	0.5	0.3	6.8	0.0	0.0	0.0	3.9	0.5	0.5	0.0	2.8	2.7	2.3	1.9	6.0	0.0	0.0	3.7	2.1	0.3	4.0	6.5	0.0	0.0	0.5	1.8	0.5	0.9	42.7	0.0	0.0	0.0	0.1	0.8	5.1	2.3	0.0	0.4	0.4	0.0	0.1	0.0	0.0	4.0	0.0	0.0	1.0	0.2	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	3.5	0.0	1.0	0.4	1.0	0.0	0.0	3.9	0.0	12.8	3.3	0.8	2.9	2.9	1.1	0.3	1.8	0.0	2.8	0.3
MYT1L	"KIAA1106, NZF1, ZC2H2C2, ZC2HC4B"	ENSG00000186487	"Myelin transcription factor 1 like"	Q9UL68	2	1789113-2331664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 45.8;pituitary gland: 14.8"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 582.4;Inhibitory neurons: 635.5;Oligodendrocyte precursor cells: 265.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 18.6;SH-SY5Y: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060245			Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA060245: AB_2732643"	"unprognostic (9.90e-3)"	"unprognostic (3.74e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.61e-3)"	"unprognostic (7.17e-2)"		"unprognostic (3.73e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	0.0	1.4	7.8	0.2	14.1	0.1	0.0	4.2	45.8	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	17.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	14.8	0.1	0.0	0.1	0.1	5.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	18.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	7.8	14.1	4.2	45.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	6.4	6.1	16.6	0.0	1.8	0.5	0.0	0.0	46.7	0.5	0.4	4.5	0.0	3.1	1.8	2.1	0.1	0.2	0.1	0.0	0.0	5.0	0.4	0.1	1.3	0.0	0.0	582.4	0.0	0.2	1.3	0.0	0.2	6.3	0.1	0.7	0.4	0.1	117.8	635.5	0.0	0.0	0.6	0.8	4.7	0.0	0.8	0.0	18.7	0.0	1.5	0.0	265.4	11.1	0.1	0.0	1.5	0.1	0.4	0.0	0.2	1.5	7.4	6.6	1.5	0.4	50.0	31.4	0.0	1.0	0.3	0.9	0.1	0.0	0.6
NKX2-2	"NKX2.2, NKX2B"	ENSG00000125820	"NK2 homeobox 2"	O95096	20	21511017-21514064	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 37.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 166.1;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 73.1"	"Group enriched"	"Detected in many"	5	"glioma: 9.5;pancreatic cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;T-47d: 4.9;U-138 MG: 17.1;U-2 OS: 3.6;WM-115: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003468	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA003468: AB_1079490"	"unprognostic (5.13e-3)"		"unprognostic (5.54e-2)"		"unprognostic (3.10e-1)"	"unprognostic (2.29e-1)"			"unprognostic (1.75e-2)"		"unprognostic (2.93e-3)"	"unprognostic (1.10e-1)"		"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"			0.0	0.0	10.2	0.0	26.1	0.0	0.0	21.6	15.3	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	14.4	0.0	0.0	0.0	0.0	30.5	22.1	0.0	4.8	0.0	7.5	0.0	26.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	16.5	0.0	2.5	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	17.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	26.1	21.6	15.3	9.7	14.4	30.5	22.1	26.9	16.5	21.1	37.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	166.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	56.8	73.1	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0
NOL4	"CT125, HRIHFB2255, NOLP"	ENSG00000101746	"Nucleolar protein 4"	O94818	18	33851100-34224952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 11.8;pituitary gland: 8.0;retina: 6.3;testis: 12.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 133.9;Early spermatids: 268.1;Excitatory neurons: 195.6;Inhibitory neurons: 207.7;Late spermatids: 95.7;Oligodendrocyte precursor cells: 326.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 36.0;SH-SY5Y: 9.5;U-698: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046740			Supported	Nucleoplasm		No	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA046740: AB_10960527"	"unprognostic (7.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.43e-7)"	"unprognostic (5.76e-2)"		"unprognostic (1.56e-2)"	"unprognostic (7.19e-2)"		"unprognostic (3.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.77e-2)"	"unprognostic (7.71e-2)"	0.0	1.8	6.1	0.1	7.2	0.0	0.1	7.6	7.8	0.5	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.1	8.2	11.6	0.7	2.2	0.2	0.2	0.8	4.1	0.0	1.7	0.0	8.0	0.0	1.0	0.3	0.7	6.3	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.7	12.6	11.8	0.0	1.6	0.0	0.2	0.5	0.0	3.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.2	0.1	0.0	0.0	0.0	36.0	9.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	7.2	7.6	7.8	8.2	11.6	0.8	4.1	1.0	2.5	11.8	3.4	0.0	0.0	0.0	133.9	0.0	0.0	0.0	0.0	0.0	17.0	0.5	1.0	0.6	0.0	0.0	0.0	2.1	0.2	0.0	0.4	1.9	0.0	268.1	0.0	0.0	0.5	73.8	0.0	195.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.1	32.0	207.7	0.2	0.0	0.0	0.0	95.7	2.5	0.1	0.0	22.5	0.0	11.6	0.0	326.8	4.5	0.1	0.1	2.2	0.0	0.0	0.0	5.3	0.0	2.1	0.0	0.0	0.0	10.9	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505532	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.8;skin 1: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.5;Cone photoreceptor cells: 75.0;Oligodendrocytes: 37.4;Rod photoreceptor cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBEC3-KT: 130.9;hTCEpi: 58.9;hTERT-HME1: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.6	1.4	1.0	3.9	1.7	2.2	6.2	7.9	4.8	6.3	0.0	1.1	2.2	0.3	1.7	19.3	3.2	2.9	0.2	2.4	1.0	0.8	2.1	1.8	5.3	3.3	3.1	0.1	5.1	0.0	7.9	0.4	3.6	14.6	0.8	44.8	16.4	5.8	0.2	59.6	3.3	0.1	1.2	5.5	2.0	0.6	6.9	4.4	1.7	0.0	6.5	9.1	18.3	7.2	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.2	0.0	17.1	0.0	130.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	58.9	0.0	32.8	0.0	0.0	0.0	0.0	3.1	0.3	0.6	0.0	0.0	0.1	1.9	1.4	0.1	0.1	0.0	0.2	6.1	14.7	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.6	0.2	1.0	1.7	7.9	4.8	2.4	1.0	3.3	3.1	3.6	1.2	6.9	7.2	0.2	0.0	1.7	2.9	6.1	15.4	14.5	22.8	10.8	102.5	1.7	5.5	3.3	2.8	10.8	0.0	75.0	0.0	7.3	0.7	1.9	0.1	0.1	0.7	0.2	0.7	1.2	0.0	9.3	0.0	0.0	0.4	1.5	1.4	0.0	0.1	0.0	4.9	0.1	26.9	19.8	1.9	2.0	0.3	1.1	0.2	0.0	0.5	3.6	1.9	0.4	14.9	7.2	2.5	37.4	0.5	0.6	0.0	1.9	4.9	3.8	33.5	5.8	169.0	0.0	0.0	1.0	0.2	0.3	13.0	14.6	0.0	7.0	0.1	0.5	9.2
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 259.7;skeletal muscle: 831.6;tongue: 271.1"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	241.3	2.6	37.1	1.1	73.6	0.3	169.8	26.1	45.7	1.6	20.4	29.6	3.0	2.2	0.7	10.3	3.8	1.5	110.9	38.9	36.9	259.7	138.1	1.0	0.5	29.0	32.0	7.7	14.2	20.8	1.8	0.0	26.0	7.9	1.8	14.6	9.7	3.2	831.6	7.6	13.2	3.3	25.5	0.5	27.8	2.2	31.6	0.2	2.6	271.1	0.5	5.4	1.5	34.1	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	73.6	26.1	45.7	38.9	36.9	29.0	32.0	26.0	25.5	31.6	34.1	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850933-60855950	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2;intestine: 8.2;stomach 1: 9.3"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Endothelial cells: 2.2;Fibroblasts: 4.1;granulocytes: 4.5;Intestinal goblet cells: 2.0;Langerhans cells: 2.4;Smooth muscle cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 178.1;eosinophil: 234.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 234.1"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;Hep G2: 4.8;HMC-1: 5.9;K-562: 4.0;MOLT-4: 3.1;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014259: AB_1849304"	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	0.6	0.0	4.3	0.6	4.2	0.0	0.6	3.3	11.2	0.4	2.3	8.2	4.4	0.4	0.2	0.8	0.6	0.5	6.7	3.4	3.6	0.1	0.5	0.6	0.1	3.7	4.2	0.1	0.5	3.4	0.3	1.0	3.9	0.5	4.1	0.1	0.1	0.1	7.3	0.4	6.9	0.3	3.0	0.5	9.3	0.3	4.2	5.0	0.1	3.9	0.1	0.5	0.2	3.4	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	9.6	0.0	4.8	1.0	0.0	5.9	1.9	0.1	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	3.1	14.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	178.1	0.1	234.1	0.0	10.9	0.0	0.0	1.5	1.1	5.2	0.0	0.0	0.0	0.7	0.1	35.8	1.1	1.6	2.3	4.3	4.2	3.3	11.2	3.4	3.6	3.7	4.2	3.9	3.0	4.2	3.4	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	1.2	0.0	0.2	0.0	0.0	4.1	0.5	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	2.4	0.0	0.3	0.5	0.0	1.9	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	6.8	0.1	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 234.3;pituitary gland: 182.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 59.0;Cone photoreceptor cells: 60.5;Enteroendocrine cells: 47.1;Excitatory neurons: 44.6;Horizontal cells: 97.6;Inhibitory neurons: 48.1;Rod photoreceptor cells: 38.4"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 66.4;U-87 MG: 249.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		38000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	0.7	25.2	91.6	4.8	98.3	0.6	0.2	12.2	139.0	0.2	0.0	5.3	1.6	0.3	0.0	0.3	0.1	0.3	0.3	116.6	234.3	0.3	0.2	0.2	0.1	62.4	85.5	0.2	36.3	0.0	182.3	0.2	138.1	0.4	0.8	21.4	0.1	0.0	0.1	0.9	2.0	1.6	22.2	0.1	6.0	0.7	98.9	0.0	0.4	0.0	0.0	0.9	0.9	70.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	2.5	0.0	0.8	0.0	0.1	0.0	0.0	1.2	4.6	6.8	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.8	1.9	0.0	0.6	8.4	0.0	20.8	0.0	0.2	0.0	0.0	0.4	0.5	1.5	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	10.8	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.1	66.4	0.0	0.2	0.1	0.3	1.1	249.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	91.6	98.3	12.2	139.0	116.6	234.3	62.4	85.5	138.1	22.2	98.9	70.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.1	0.0	59.0	0.1	0.1	2.0	0.0	0.0	0.0	60.5	0.0	0.1	0.1	1.9	0.1	0.3	0.1	0.2	0.7	47.1	2.7	44.6	0.0	0.3	1.9	2.6	0.0	0.0	0.0	0.0	0.3	0.1	97.6	48.1	0.7	2.0	0.0	0.4	0.8	0.3	1.8	1.8	4.7	0.0	6.0	0.0	1.5	4.0	2.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	38.4	0.0	0.1	1.9	4.2	2.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959906-79090780	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 26.5;lung: 7.5;retina: 7.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	0.1	0.1	4.2	1.0	4.1	0.0	0.1	24.4	24.4	0.6	0.0	0.2	0.2	0.4	0.1	0.1	0.4	0.1	0.0	12.2	6.4	0.7	0.0	7.5	1.3	13.9	10.2	0.8	2.3	0.6	1.1	0.2	16.4	0.5	0.2	7.4	0.1	0.2	0.0	0.0	1.4	0.1	8.7	0.6	0.2	0.3	14.9	0.5	0.0	0.0	1.4	0.3	0.1	26.5	8.5	0.1	0.1	0.0	0.0	0.0	7.7	0.0	0.4	0.5	1.2	0.0	1.5	0.4	0.2	0.0	0.6	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	10.4	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	13.0	0.1	0.3	0.8	0.0	0.0	0.1	1.6	0.7	0.0	1.7	0.0	0.0	15.1	0.0	0.3	0.0	3.8	2.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.1	24.4	24.4	12.2	6.4	13.9	10.2	16.4	8.7	14.9	26.5	0.2	3.2	80.6	8.5	4.5	0.6	0.6	0.2	0.0	13.7	0.2	0.1	1.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.6	0.4	0.5	0.0	0.0	80.9	0.0	2.7	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.0	25.2	91.2	0.0	0.0	0.3	16.1	0.0	0.0	1.8	3.6	5.6	0.6	1.1	0.0	1.5	121.5	0.3	0.0	0.4	2.1	0.2	0.0	6.8	2.0	2.5	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.8	0.1	1.6	0.0	0.4
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 28.9;SH-SY5Y: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.6	14.5	6.3	0.9	11.3	0.2	0.2	0.0	17.5	7.2	17.3	1.5	2.9	2.7	2.5	0.5	7.8	0.9	0.0	25.9	19.2	5.9	0.2	0.4	0.1	1.7	19.6	2.1	2.5	24.6	32.2	0.0	20.6	1.1	1.8	11.2	0.3	1.3	0.2	2.7	2.5	2.4	0.1	1.0	5.9	2.6	0.9	0.3	0.6	3.9	0.1	0.3	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.0	0.4	7.3	0.0	0.0	28.9	55.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	11.3	0.0	17.5	25.9	19.2	1.7	19.6	20.6	0.1	0.9	2.7	0.4	0.0	0.0	5.9	0.0	2.0	0.1	0.0	0.6	19.4	0.0	0.1	1.4	0.0	0.0	0.0	31.3	0.0	0.0	0.4	0.0	0.0	3.8	3.0	1.4	0.4	75.5	0.0	128.2	0.0	0.0	0.7	4.1	6.4	0.0	0.0	0.0	0.0	0.0	10.1	191.4	2.6	6.1	0.0	0.5	2.1	0.9	0.0	0.0	1.0	0.0	3.2	0.0	19.6	5.3	0.1	0.1	0.7	0.0	0.1	0.0	0.1	0.7	14.0	0.0	0.0	0.2	1.7	1.5	0.1	0.6	0.0	0.1	0.0	0.8	0.0
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690442-64718190	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	9	"brain: 3.0;pancreas: 4.9;stomach 1: 2.8"	"Group enriched"	"Detected in some"	13	"Breast glandular cells: 1.8;Pancreatic endocrine cells: 1.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 9.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA011778	Enhanced					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	4.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	9.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	3.0	1.4	0.2	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338381-22379503	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.4;Rod photoreceptor cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	229	"SCLC-21H: 30.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 51.9;hypothalamus: 139.9;midbrain: 172.4;pons and medulla: 86.4;thalamus: 164.9"	"Low region specificity"	"Detected in many"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.0	0.0	6.6	0.0	1.5	0.0	0.0	13.4	11.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	16.6	0.0	0.0	0.0	0.0	38.3	16.1	0.0	0.2	0.0	3.6	0.0	35.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	13.4	11.0	3.8	16.6	38.3	16.1	35.6	7.1	39.6	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 61.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.2	0.2	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.2	4.3	0.0	0.1	0.1	0.2	0.1	0.0	61.8	0.3	0.3	0.3	0.3	0.1	0.2	0.2	12.9	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.2	0.3	0.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.1;pituitary gland: 17.9;retina: 11.1;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	0.2	3.1	6.7	0.9	7.5	0.6	1.3	10.3	18.1	1.1	0.0	0.4	0.4	0.3	2.5	0.1	1.7	0.3	0.3	9.8	10.6	1.9	0.1	1.2	1.4	23.3	8.6	3.3	1.0	2.2	17.9	0.2	24.1	0.4	0.4	11.1	0.9	0.6	0.1	0.2	0.8	0.3	3.6	1.0	1.3	11.7	9.0	0.6	0.2	0.0	1.2	0.2	0.1	11.4	0.2	1.0	11.9	0.1	0.5	0.6	21.0	3.3	5.5	5.2	3.3	7.2	0.2	4.5	0.5	4.5	2.9	0.1	4.7	0.2	4.8	0.9	0.6	2.3	0.3	0.0	0.0	0.7	14.8	0.2	0.2	2.7	0.5	3.1	6.2	1.9	0.1	7.6	2.7	2.6	6.6	1.4	5.1	1.4	3.6	0.1	0.0	0.0	0.6	0.1	15.7	10.7	1.3	1.6	0.0	3.6	2.0	0.5	5.7	3.3	1.7	0.2	4.3	3.8	1.3	0.2	4.6	0.6	0.4	0.4	0.5	0.9	0.4	0.3	0.0	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.5	0.8	0.2	0.0	0.2	6.7	7.5	10.3	18.1	9.8	10.6	23.3	8.6	24.1	3.6	9.0	11.4	1.2	0.0	8.7	33.6	3.1	0.0	0.8	0.2	0.0	92.6	5.0	1.5	1.9	0.0	5.4	1.8	179.3	1.4	4.9	0.5	7.9	0.1	61.9	1.7	0.6	2.4	6.0	0.8	115.0	1.3	5.2	2.1	13.3	0.7	7.6	11.5	1.1	0.2	2.2	116.1	127.8	0.4	0.0	4.7	2.2	32.8	2.8	4.5	1.8	18.7	3.4	11.5	7.2	20.1	248.9	0.1	5.4	3.8	3.5	1.0	1.9	1.0	25.0	19.9	0.0	0.7	1.0	91.9	8.2	0.1	0.1	0.4	4.3	0.9	0.2	1.1
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150494-110202202	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.9;pituitary gland: 25.3"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 60.6;Inhibitory neurons: 59.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	0.4	5.9	21.6	0.2	26.3	0.1	0.3	1.2	52.9	0.1	0.0	0.3	0.0	0.1	1.0	0.4	0.1	0.1	0.1	20.1	9.6	1.3	0.0	0.1	0.0	13.7	8.2	0.0	1.4	8.8	25.3	0.8	10.5	0.1	0.1	6.0	0.6	0.1	0.1	6.2	0.1	0.1	0.0	0.0	0.7	1.8	24.8	0.0	0.3	0.1	0.0	0.1	0.1	15.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.5	0.5	2.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.8	6.2	1.9	36.0	1.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	7.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	26.3	1.2	52.9	20.1	9.6	13.7	8.2	10.5	0.0	24.8	15.7	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.1	0.0	5.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	1.2	0.0	0.0	0.5	0.0	0.0	60.6	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	59.4	0.0	4.1	0.0	0.0	0.7	0.0	0.0	10.6	3.7	0.0	0.7	0.0	4.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.7	0.4	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204237-37212477	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;lymphoid tissue: 11.1;testis: 7.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 23.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.3	2.2	1.0	2.2	0.4	0.0	1.2	6.4	0.0	0.0	0.2	1.3	1.1	0.0	0.0	0.1	0.0	0.0	1.9	2.2	0.1	0.0	0.0	1.8	6.8	3.5	3.3	1.8	0.0	2.6	0.0	6.7	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.5	1.0	1.2	0.6	0.2	7.8	7.6	11.1	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.2	2.2	2.2	1.2	6.4	1.9	2.2	6.8	3.5	6.7	1.2	7.6	2.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0
STXBP5L	"KIAA1006, LLGL4"	ENSG00000145087	"Syntaxin binding protein 5 like"	Q9Y2K9	3	120908072-121424761	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 69.0"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 1544.2;Inhibitory neurons: 529.4;Oligodendrocyte precursor cells: 390.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"cerebellum: 69.0;cerebral cortex: 25.6;hippocampal formation: 19.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;HeLa: 4.7;MOLT-4: 6.6;NTERA-2: 3.5;RH-30: 3.3;SCLC-21H: 8.8;SH-SY5Y: 3.9;U-937: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.42e-1)"	"unprognostic (9.47e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.89e-2)"		"unprognostic (7.01e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.61e-3)"	0.0	1.8	3.8	0.0	6.4	0.0	0.0	69.0	25.6	0.6	0.0	1.2	0.3	0.9	0.0	0.3	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	9.4	0.2	0.0	2.9	0.0	3.8	2.1	0.2	4.3	0.1	3.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	2.1	0.0	0.0	7.6	0.0	0.0	0.9	0.3	4.4	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	6.6	0.0	3.5	0.0	0.7	0.0	3.3	0.0	0.0	0.6	8.8	3.9	0.0	0.0	0.1	0.0	0.9	2.5	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	1.7	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.4	69.0	25.6	19.1	0.0	4.3	0.0	3.8	0.0	0.0	4.4	0.0	0.0	0.0	51.2	0.0	0.1	0.9	0.0	0.0	32.8	0.0	0.0	0.5	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.3	0.1	12.1	0.0	1544.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	10.1	529.4	0.6	0.0	0.0	0.0	12.8	2.8	0.0	0.0	24.4	0.0	0.8	0.0	390.6	27.9	0.1	0.1	0.4	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.7	0.3	11.2	7.2	0.0	0.0	0.0	0.0	3.6	0.0	0.2
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021068	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 14.3;pituitary gland: 7.4;retina: 13.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 41.7;Early spermatids: 65.4;Excitatory neurons: 70.3;Inhibitory neurons: 75.8;Late spermatids: 121.5"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Karpas-707: 2.8;RPMI-8226: 3.0;SCLC-21H: 1.5;SH-SY5Y: 1.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.0	1.5	11.2	0.1	12.4	0.1	0.0	2.2	14.3	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	1.0	11.3	9.5	0.1	0.2	0.0	0.0	2.9	2.1	0.0	0.7	0.0	7.4	0.0	3.7	0.0	0.1	13.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.7	0.5	6.4	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.5	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	11.2	12.4	2.2	14.3	11.3	9.5	2.9	2.1	3.7	0.4	6.4	6.0	0.2	12.8	9.6	2.6	0.1	0.0	0.7	0.0	0.0	19.7	0.1	0.0	1.3	0.0	5.0	1.8	41.7	1.3	0.0	0.1	0.0	0.1	65.4	0.1	0.1	1.0	16.8	0.0	70.3	0.0	0.3	0.6	0.0	0.2	2.5	0.1	1.1	0.1	0.1	11.8	75.8	0.0	0.0	0.0	0.0	121.5	0.3	1.0	0.0	1.0	0.1	2.1	0.0	4.0	2.8	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.0	21.9	0.0	1.5	0.7	0.7	0.9	0.0	0.0	0.8	0.5	0.1	0.0	0.4
SYT16	"CHR14SYT, Strep14, SYT14L, yt14r"	ENSG00000139973	"Synaptotagmin 16"	Q17RD7	14	61811974-62112550	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.5"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 281.4;Inhibitory neurons: 279.7;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.8;hTERT-HME1: 4.1;PC-3: 5.4;RPTEC TERT1: 6.2;RT4: 17.0;U-2 OS: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004199, HPA076871"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA004199: AB_1080156, HPA076871: AB_2732324"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (8.88e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.08e-2)"		"unprognostic (9.57e-2)"	"unprognostic (9.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.15e-1)"	0.0	0.4	7.5	0.0	11.0	0.1	0.1	0.0	16.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.1	12.7	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	1.1	0.4	0.0	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	3.8	3.8	0.0	0.0	0.0	0.0	0.3	0.2	0.4	10.8	0.2	0.3	0.0	0.0	0.0	0.1	0.7	1.0	1.0	0.6	0.0	0.0	0.1	0.2	0.0	0.6	0.6	0.0	1.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	6.2	17.0	0.3	2.8	0.5	0.7	0.0	1.0	0.0	0.0	0.0	2.7	6.6	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	0.0	16.5	12.7	8.0	0.0	0.0	0.0	0.1	3.8	0.4	0.0	0.0	0.0	8.8	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.3	0.0	0.0	3.7	2.1	0.7	0.0	0.0	0.0	0.3	45.0	0.1	0.4	0.1	0.0	0.0	281.4	0.0	0.6	0.1	3.1	0.3	0.0	3.4	0.0	0.0	0.1	0.0	279.7	0.0	0.0	0.0	0.0	17.1	0.3	0.0	0.0	8.4	0.0	0.7	0.0	127.2	13.9	0.1	0.0	0.0	0.3	1.7	0.0	0.2	0.1	0.1	0.0	0.0	0.4	3.8	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998739-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7"	"Cancer enriched"	"Detected in many"	4	"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA		9000000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	0.3	33.5	291.3	1.5	313.2	0.0	0.1	250.3	442.4	0.0	172.3	11.4	0.6	0.0	0.0	0.2	0.0	0.2	0.6	318.0	310.2	4.5	0.3	0.5	0.2	300.5	235.8	0.3	5.6	0.0	100.9	0.0	292.8	0.5	2.3	74.3	0.2	0.2	0.2	0.6	2.4	1.1	212.3	0.1	3.3	0.3	254.2	1.3	0.4	0.0	0.2	0.2	1.1	309.3	0.0	0.0	104.1	0.2	0.0	0.0	0.1	2.6	1.9	0.1	0.1	0.4	0.2	0.0	3.8	0.0	0.1	0.7	0.1	7.2	1.4	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.0	0.1	0.0	4.0	0.0	9.0	15.1	2.8	0.0	41.6	0.0	55.5	94.5	0.0	0.1	0.0	2.1	0.1	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.3	313.2	250.3	442.4	318.0	310.2	300.5	235.8	292.8	212.3	254.2	309.3	0.1	0.0	0.0	16.6	0.0	0.8	1.2	1.0	0.0	104.3	0.2	0.3	0.7	0.0	1.8	5.5	8.4	0.0	0.1	0.0	0.0	0.1	2.6	0.2	0.0	1.1	5.3	0.0	78.1	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	297.8	49.3	0.0	30.5	0.0	0.0	0.9	0.0	0.4	0.0	15.0	0.0	16.3	0.0	32.2	18.8	2.3	0.0	0.0	0.0	1.1	0.0	31.9	12.8	50.7	0.0	0.4	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.9
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171815	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"adrenal gland: 196.6;brain: 270.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	5	"midbrain: 192.4;pons: 270.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"PC-3: 60.8;SK-BR-3: 21.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 178.8"	"Region enriched"	"Detected in many"	20	"midbrain: 594.4"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	3.3	196.6	1.9	0.1	3.0	0.0	0.0	0.2	1.3	0.6	0.2	0.1	0.0	0.5	0.1	0.7	0.2	0.4	0.1	1.3	46.5	0.4	0.4	0.0	0.0	13.9	192.4	0.7	0.2	0.0	1.7	0.1	270.9	0.3	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.8	0.2	0.3	0.5	14.6	0.0	0.0	0.0	0.0	1.4	1.5	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	60.8	0.0	0.0	0.0	0.1	0.1	1.1	0.2	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.2	1.3	1.3	46.5	13.9	192.4	270.9	0.8	14.6	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.4	9.0	0.4	0.0	0.0	0.1	0.0	12.4	0.4	0.0	0.3	0.0	0.0	1.1	0.2	0.5	0.0	0.3	0.1	0.0	0.0	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	2.2	0.1	0.3	0.2	0.2
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 31.5;pituitary gland: 88.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 58.1;Horizontal cells: 65.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	0.2	11.4	18.9	0.3	19.3	0.0	0.1	12.0	29.7	0.1	4.6	3.8	0.2	0.1	0.4	0.1	0.3	0.1	1.0	17.8	24.6	0.5	0.5	0.1	0.0	25.9	24.9	0.1	4.0	0.1	88.1	0.8	31.5	0.8	0.2	6.2	0.1	0.1	0.1	0.0	1.4	0.3	12.5	0.0	1.3	5.2	18.8	0.0	0.1	0.0	0.0	0.1	0.7	20.5	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	37.3	11.6	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	19.3	12.0	29.7	17.8	24.6	25.9	24.9	31.5	12.5	18.8	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	65.6	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	1.5	0.0	7.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719315-19773617	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.4;retina: 21.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 4.8;ASC TERT1: 4.5"					"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.3	1.3	2.6	0.0	4.4	0.0	0.0	0.0	4.1	0.4	0.0	0.1	0.0	1.4	0.4	0.0	0.3	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	3.6	6.7	0.0	1.1	0.0	3.7	0.0	3.3	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	4.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	4.1	2.7	10.4	3.6	6.7	3.3	1.9	7.1	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	116.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	90.9	0.4	0.0	0.0	45.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	3.3	23.9	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.9	0.0	2.6	0.0	127.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TUNAR	"HI-LNC78, LINC00617, TUNA"	ENSG00000250366	"TCL1 upstream neural differentiation-associated RNA"		14	95876392-95925663	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"brain: 42.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Endometrial ciliated cells: 11.5;Endometrial stromal cells: 8.9;Excitatory neurons: 4.6;Glandular and luminal cells: 16.8;Spermatogonia: 3.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 16.3;HAP1: 7.0;NTERA-2: 11.8;SCLC-21H: 16.1;SuSa: 4.6"															NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.28e-3)"			"unprognostic (3.94e-1)"	"unprognostic (4.10e-2)"					"unprognostic (1.69e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.18e-1)"		0.0	0.1	6.3	0.1	42.5	0.3	0.4	5.6	10.8	0.3	0.0	0.0	0.1	6.5	0.1	0.0	8.5	0.1	0.0	9.5	9.6	0.2	0.0	0.0	0.3	30.8	12.0	0.1	2.7	0.0	1.2	0.0	30.5	0.0	0.0	8.5	0.0	3.5	0.0	0.1	0.0	0.0	11.6	0.1	0.5	1.3	23.0	0.1	1.1	0.0	0.2	0.0	0.0	3.9	0.0	0.1	16.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	7.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	11.8	0.0	0.1	0.7	0.0	0.0	0.4	0.1	16.1	1.3	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	42.5	5.6	10.8	9.5	9.6	30.8	12.0	30.5	11.6	23.0	3.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.0	2.8	11.5	8.9	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
UNC13A	"KIAA1032, Munc13-1"	ENSG00000130477	"Unc-13 homolog A"	Q9UPW8	19	17601328-17688365	"Predicted intracellular proteins"	"Differentiation, Exocytosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 24.0;pituitary gland: 32.2;retina: 18.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.9;Cone photoreceptor cells: 54.2;Excitatory neurons: 85.3;Horizontal cells: 119.5;Inhibitory neurons: 67.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Group enriched"	"Detected in many"	15	"amygdala: 8.3;basal ganglia: 15.8;cerebral cortex: 24.0;hippocampal formation: 19.0;white matter: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 16.2;NTERA-2: 23.7;SCLC-21H: 38.9;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.50e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.00e-1)"	0.1	2.5	8.3	0.4	15.8	0.0	0.0	0.0	24.0	0.3	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.0	19.0	1.0	0.3	0.0	0.2	0.3	0.0	0.0	0.2	1.4	0.1	32.2	0.2	0.0	0.1	0.2	18.8	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.0	0.8	0.7	0.0	0.1	0.2	0.0	0.3	0.1	0.1	8.8	0.0	2.4	2.0	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	2.4	0.6	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	16.2	0.0	0.0	0.0	1.5	0.4	0.0	0.1	2.0	0.1	0.0	0.2	0.0	0.0	23.7	0.2	0.6	0.6	0.0	0.3	0.0	0.0	38.9	9.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.8	0.0	24.0	19.0	1.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	6.5	0.0	0.3	0.3	0.1	0.0	43.9	0.1	0.3	2.1	0.0	0.0	0.0	54.2	0.0	0.2	0.3	0.0	1.5	0.0	0.1	0.2	1.0	8.4	0.0	85.3	0.2	0.0	1.5	0.0	0.5	0.0	0.4	0.0	0.0	0.2	119.5	67.0	0.0	2.0	0.0	0.3	0.1	0.0	0.2	0.0	3.7	1.6	3.3	0.0	18.1	2.8	1.1	0.0	1.5	0.0	0.4	0.0	0.1	0.0	22.7	0.0	0.6	0.6	0.2	1.8	0.0	0.0	0.0	0.0	1.8	0.5	0.3
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129288-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;thyroid gland: 16.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.7;Excitatory neurons: 30.1;Horizontal cells: 21.9;Inhibitory neurons: 27.7;Oligodendrocyte precursor cells: 9.5"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"RT4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	0.9	0.7	8.9	0.1	14.3	0.0	0.8	36.7	13.9	3.5	0.3	3.3	0.3	10.1	2.1	1.0	2.6	0.1	0.4	17.9	4.2	1.0	0.0	0.3	0.1	0.6	2.4	0.3	1.4	0.0	1.4	0.2	2.2	4.2	0.3	11.9	0.3	13.5	0.2	0.8	0.7	6.8	2.7	0.1	1.9	0.2	10.0	0.0	16.8	0.4	0.1	2.5	1.3	7.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.4	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.9	14.3	36.7	13.9	17.9	4.2	0.6	2.4	2.2	2.7	10.0	7.2	0.8	0.0	0.0	5.9	0.6	0.1	0.0	0.1	0.0	43.7	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	30.1	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.7	0.0	0.0	21.9	27.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	2.8	0.0	0.3	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0